Will emerging pharmacotherapies improve the management of polycystic ovarian syndrome?
- Resource Type
- Authors
- Fulvio Zullo; Morena Rocca; Rita Mocciaro; Michele Morelli; Roberta Venturella
- Source
- Expert Opinion on Emerging Drugs. 21:1-4
- Subject
- Adult
Pharmacology
Gynecology
medicine.medical_specialty
030219 obstetrics & reproductive medicine
Adolescent
business.industry
Metabolic disorder
medicine.disease
Polycystic ovary
female genital diseases and pregnancy complications
Young Adult
03 medical and health sciences
0302 clinical medicine
Drug Design
medicine
Humans
Female
Pharmacology (medical)
030212 general & internal medicine
business
Human
Polycystic Ovary Syndrome
- Language
- ISSN
- 1744-7623
1472-8214
Polycystic ovary syndrome (PCOS) is the most common metabolic disorder in reproductive aged women, affecting approximately 5–15% of this population.[1]The Rotterdam Criteria [2] have been accepted ...